To further study whether SFX can inhibit the secretion of sEV from transplanted cancer cells in vivo, we determined the amounts of circulating human cancer cells-derived sEV in the sera of host mice by using the specific antibody recognizing the human CD63 but not the mouse CD63 (ref. 12). This evidence concerns the gene CD63 and cancer.